Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Ampio Pharmaceuticals AMEX AMPE
$0.33 0.08 23.94%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 22 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

274.57K
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-3.54M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.73
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
832.02K
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-83.90 %
Upcoming events Ampio Pharmaceuticals All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Ampio Pharmaceuticals

Stock analysis Ampio Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-0.03 -0.09
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.08 0.42
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
0.39 -4.43
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
0.43 0.42
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
-247.89 -51.45

Price change Ampio Pharmaceuticals per year

0.72$ 2.98$
Min Max

Summary analysis Ampio Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Ampio Pharmaceuticals

Revenue and net income Ampio Pharmaceuticals

All parameters
Stock news Ampio Pharmaceuticals All news
29 February в 00:20

Ampio Pharmaceuticals Up 26% on Securities-Sale Updates

3 August 2022 в 16:15

Ampio Pharmaceuticals Fires Two Executives After Investigation

3 August 2022 в 16:11

Ampio Pharmaceuticals Fires Two Executives After Investigation

21 April 2022 в 14:41

Ampio Pharmaceuticals Shares Slide Premarket on Ampion FDA Setback >AMPE

21 April 2022 в 14:41

Ampio Pharmaceuticals Shares Slide Premarket on Ampion FDA Setback >AMPE

24 March 2022 в 14:21

Ampio Pharmaceuticals started at buy with $4.50 stock price target at Alliance Global Partners

22 November 2021 в 17:35

Ampio Pharmaceuticals Chairman, CEO Mike Macaluso Taking Medical Leave >AMPE

22 November 2021 в 17:35

Ampio Pharmaceuticals Chairman, CEO Mike Macaluso Taking Medical Leave >AMPE

13 October 2021 в 16:45

Ampio Pharmaceuticals Names Oper Chief Cherevka to Added President Post >AMPE

13 October 2021 в 16:40

Ampio Pharmaceuticals Names Oper Chief Cherevka to Added President Post >AMPE

About company Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunology-based therapies for the treatment of prevalent inflammatory conditions in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-016, an intravenous treatment that is in Phase I/II clinical trial for COVID-19 patients with respiratory illness; and AP-014, an inhaled treatment that is in Phase I clinical trial for COVID-19 induced respiratory distress. The company is headquartered in Englewood, Colorado.
Address:
373 Inverness Parkway, Englewood, CO, United States, 80112
Company name: Ampio Pharmaceuticals
Issuer ticker: AMPE
ISIN: US03209T1097
Country: USA
Exchange: AMEX
Currency: $
IPO date: 2010-03-31
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.ampiopharma.com

On which stock exchange are Ampio Pharmaceuticals (AMPE) stocks traded?

Ampio Pharmaceuticals (AMPE) stocks are traded on AMEX.

What is the ticker of Ampio Pharmaceuticals stocks (AMPE)?

The stock ticker of Ampio Pharmaceuticals’s stocks or in other words, the code is AMPE. The stocks are currently listed on the AMEX exchange.

In which sector and industry does Ampio Pharmaceuticals (AMPE) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Ampio Pharmaceuticals (AMPE) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Ampio Pharmaceuticals (AMPE) stocks traded?

Ampio Pharmaceuticals (AMPE) stocks are traded on the AMEX exchange in dollars.

What is the price of Ampio Pharmaceuticals (AMPE) stocks today?

The current price of Ampio Pharmaceuticals stocks on 02.05.2024 is 0.33 dollars. per share.

What is the dynamics of Ampio Pharmaceuticals (AMPE) stocks from the beginning of the year?

Ampio Pharmaceuticals (AMPE) quotes have increased by -84.13% from the beginning of the year up to 0.33 dollars. per 1 stocks.

How much did Ampio Pharmaceuticals (AMPE) stocks increase in мае 2024?

This month Ampio Pharmaceuticals (AMPE) quotes have increased by 0% to 0.33 dollars. per share.

How much are Ampio Pharmaceuticals (AMPE) stocks worth?

Today, on October, 02.05.2024 Ampio Pharmaceuticals’s (AMPE) stocks cost 0.33 dollars..

What is the market capitalization of Ampio Pharmaceuticals (AMPE)?

Capitalization is the market value of Ampio Pharmaceuticals (AMPE) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 02.05.2024, the market capitalization of Ampio Pharmaceuticals (AMPE) is estimated at about 274567 dollars.